Sheridan Capital Partners Closes Fund III at $575 Million and Expands Healthcare Investments

Investment firm Sheridan Capital Partners has successfully closed its third buyout fund, Sheridan Capital Partners Fund III, LP, and its parallel fund at the hard cap of $575 million. The fund exceeded its target of $450 million, demonstrating strong support from global investors. Sheridan Capital Partners focuses on investments in recession-resistant, non-discretionary markets within the healthcare industry and will continue its strategy of making control investments in North American founder-owned businesses.

Jonathan Lewis, Founder & Partner of Sheridan, expressed his gratitude for the support of both existing and new investors in closing the fund in a challenging macroeconomic environment. He also emphasized the confidence the investors have shown in Sheridan Capital Partners and their commitment to pursuing opportunities within the lower middle market healthcare sector.

Fund III attracted a diverse range of international investors, including insurance companies, consultants, pensions, family offices, sovereign wealth funds, and fund-of-funds. This mix of limited partners spans across North America, Europe, and the Middle East, further highlighting the global appeal of Sheridan Capital Partners' investment strategy.

Sean Dempsey, Partner of Sheridan, emphasized the strong performance of the healthcare sector across business cycles and highlighted the firm's commitment to partnering with founder-owned businesses. By leveraging their sector expertise and operational approach, Sheridan Capital Partners aims to accelerate growth and create long-term value for investors, business owners, and management teams.

To facilitate the successful closing of Fund III, Sixpoint Partners acted as the exclusive global placement agent, while Kirkland & Ellis LLP served as fund counsel, ensuring a smooth and efficient process.

Sheridan Capital Partners, a Chicago-based private equity firm, specializes in lower middle market buyouts and growth equity in the healthcare industry in the U.S. and Canada. The firm focuses on investments in providers and provider services, healthcare IT and outsourced services, and consumer health and medical products. By providing strategic resources, Sheridan Capital Partners aims to accelerate growth, build enduring value, and achieve strong results for its portfolio companies.

For more information about Sheridan Capital Partners, please visit their website at [www.sheridancp.com](https://www.sheridancp.com).